GABA_A R α 5 Antibodies

Santa Cruz Biotechnology delivers a wide array of GABA_A R α 5 monoclonal antibodies for neuroscience and pharmacology research. GABA_A R α 5 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GABA_A R α 5 is a crucial subunit of the GABA_A receptor, which plays a vital role in mediating inhibitory neurotransmission in the central nervous system. The GABA_A receptor is involved in various physiological processes, including anxiety, learning, and memory, making it a significant target for therapeutic interventions in neurological disorders. Understanding the function and regulation of GABA_A R α 5 is essential for advancing research in synaptic transmission and developing new treatments for conditions such as epilepsy and anxiety disorders. Researchers worldwide rely on GABA_A R α 5 monoclonal antibodies to explore neural pathways and mechanisms. Current studies focusing on GABA_A R α 5 continue to reveal new insights into neurotransmitter signaling and potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific knowledge and developing innovative therapeutic strategies for neurological conditions.